SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-078344
Filing Date
2020-03-19
Accepted
2020-03-19 08:36:02
Documents
3
Period of Report
2020-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d901631d8k.htm 8-K 21875
2 EX-99.1 d901631dex991.htm EX-99.1 71660
3 GRAPHIC g901631g0319031019860.jpg GRAPHIC 2209
  Complete submission text file 0001193125-20-078344.txt   98054
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 20726499
SIC: 2834 Pharmaceutical Preparations